HEALTHCARE & REMOTE PATIENT MONITORING

RESP® Biosensor

Manage lung health from hospital to home with objective monitoring of symptoms

FDA 510(k) Class II Device | CE Mark | HIPAA Compliant

Technology Overview

Developed by an asthma patient, the RESP® Biosensor offers clinicians and healthcare teams a novel approach to improve disease surveillance with at-risk patients.

Continuous lung sound monitoring: High-fidelity wearable device continuously captures lung sounds to extend the range of stethoscope auscultation.
Patient-friendly device: Wireless, discreet design that respects patient comfort and lifestyle.
Clinically validated: Demonstrated reliability, accuracy, and ease of use in several patient populations. View publications

OVERVIEW VIDEO

“With this information we can predict if the patient is doing better or worse and intervene ahead of time to prevent the patient from having major complications”

– Sadia Benzaquen, MD, Chair of Pulmonary Critical Care, Einstein Medical Center

Track Patient Progress Objectively and Remotely

Patient reports include accurate, time-stamped data on signs and symptoms such as coughing and wheezing, allowing for greater diagnostics and insight into treatment response.

KEY FEATURES

Passive & continuous
Wireless & lightweight
HIPAA compliant
Reimbursable under RTM & RPM codes
24+ hour battery life
Rechargeable
EHR/telehealth integration
Proprietary machine learning algorithms* for event detection

*Machine learning algorithms not FDA cleared

The Strados Difference

LUNG ACOUSTICS

The primary distinction between our device and standard of care is our ability to extend the range of the stethoscope. Abnormal lung sounds such as cough, wheeze, rhonchi, and crackles can indicate various respiratory issues, including airway obstruction, fluid accumulation, or inflammation. These sounds often offer the earliest signs of respiratory distress or disease exacerbation.